- In this section:
- Contact our NeoBiotechologies specialists
Founded in 2013, NeoBiotechnologies provides highly validated antibody solutions for cancer researchers, diagnostic laboratories, and life science professionals. With a focus on immuno-oncology, cancer diagnostics, immunology, neuroscience, and signal transduction, and a portfolio of monoclonal antibodies, recombinant antibodies, transcription factor antibodies, and IHC reagents, NeoBiotechnologies is committed to improving research reproducibility, advancing cancer research, and supporting the development of more effective diagnostic and therapeutic solutions.
Cambridge Bioscience is pleased to provide NeoBiotechnologies products in the UK and Ireland.
Monoclonal antibodies, recombinant antibodies, transcription factor antibodies, IHC reagents, HuProt™ MicroArrays, Validated antibodies, MonoPolys antibodies, Polyclonal antibodies, antibody validation, cancer markers, cell markers, SDS-PAGE, western blot, flow cytometry, IHC
